Pinsent Masons LLP
We are only able to display limited information for this firm. We display more complete information for all of the following firms:
Pinsent Masons LLP‘s life sciences and healthcare groups are well-equipped to handle a range of disputes, transactions and regulatory mandates. The firm is particularly well-known for assisting generic companies in patent litigation. Noted for her capabilities advising life sciences clients on various IP, data, FOI and AI issues, Karen Gallagher leads the life sciences team alongside co-head Neil Keenan, who has a wealth of experience handling corporate transactions in the sector, including assisting clients with fundraisings and subsequent exits. With a focus on healthcare transactions, Dorian Rees leads the healthcare offering. Maureen Daly is another key name to note.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
- ‘Dorian Rees has been a very supportive and is a well versed partner looking after all our requirements. He goes above and beyond but also keeps us informed of next steps requirements and annual legal requirements, which saves us a lot of headaches.’
- ‘Unparalleled strategic thinking, intimate and deep knowledge of the Life Sciences sector, coupled with a respect and understanding of the difficulties and challenges faced by SMEs like ours operating in the space. The global reach and expertise that Pinsents offers has been incredibly important for us in establishing a robust supply chain spanning several continents.'
Key clients
- Sandoz
- ReproMed
Work highlights
Advising Teva in a dispute challenging the validity of BMS’ compound patent/SPC in respect of apixaban/Eliquis , as well as three sets of related proceedings concerning Eliquis, including compound infringement proceedings, and revocation and infringement proceedings concerning six formulation patents protecting the product.